Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project

Talar W. Markossian, Elizabeth Calhoun

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. Methods: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. Results: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. Conclusions: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.

Original languageEnglish (US)
Pages (from-to)52-59
Number of pages8
JournalHealth Policy
Volume99
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Breast Neoplasms
Costs and Cost Analysis
Cost-Benefit Analysis
Neoplasms
SEER Program
Information Storage and Retrieval
Early Detection of Cancer
Survival
Therapeutics

Keywords

  • Breast cancer
  • Cost-effectiveness analysis
  • Health care disparities
  • Patient navigation

ASJC Scopus subject areas

  • Health Policy

Cite this

Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project. / Markossian, Talar W.; Calhoun, Elizabeth.

In: Health Policy, Vol. 99, No. 1, 01.2011, p. 52-59.

Research output: Contribution to journalArticle

@article{42d18a8d3a624f7caac4db8cc1015ecc,
title = "Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project",
abstract = "Objectives: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. Methods: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. Results: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. Conclusions: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.",
keywords = "Breast cancer, Cost-effectiveness analysis, Health care disparities, Patient navigation",
author = "Markossian, {Talar W.} and Elizabeth Calhoun",
year = "2011",
month = "1",
doi = "10.1016/j.healthpol.2010.07.008",
language = "English (US)",
volume = "99",
pages = "52--59",
journal = "Health Policy",
issn = "0168-8510",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Are breast cancer navigation programs cost-effective? Evidence from the Chicago Cancer Navigation Project

AU - Markossian, Talar W.

AU - Calhoun, Elizabeth

PY - 2011/1

Y1 - 2011/1

N2 - Objectives: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. Methods: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. Results: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. Conclusions: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.

AB - Objectives: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. Methods: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. Results: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. Conclusions: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.

KW - Breast cancer

KW - Cost-effectiveness analysis

KW - Health care disparities

KW - Patient navigation

UR - http://www.scopus.com/inward/record.url?scp=78649937691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649937691&partnerID=8YFLogxK

U2 - 10.1016/j.healthpol.2010.07.008

DO - 10.1016/j.healthpol.2010.07.008

M3 - Article

C2 - 20685001

AN - SCOPUS:78649937691

VL - 99

SP - 52

EP - 59

JO - Health Policy

JF - Health Policy

SN - 0168-8510

IS - 1

ER -